JPRN-UMIN000013268已完成未知
Efficacy of anti-RANKL antibody on bone and mineral disorders in post-kidney transplant patients. - Anti-RANKL antibody after kidney transplantation
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Person incapable of giving informed consent
研究者
相似试验
已完成
不适用
Efficacy of the anti-RANKL human antibody (Denosumab) versus Bisphosphonate for the treatment of osteoporosis in patients with primary biliary cirrhosisOsteoporosis in biopsy-proven primary biliary cirrhosis patients pretreated with bisphosphonateJPRN-UMIN000012193Juntendo University School of Medicine60
已完成
不适用
Effect of osteoporosis therapy with RANKL inhibitor on coronary calcificationsJPRN-UMIN000026938Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences11
已完成
2 期
Effect of Denosumab in Erosion Healing in RARheumatoid ArthritisNCT03239080Chinese University of Hong Kong110
已完成
不适用
Efficacy of a human anti-RANKL antibody (Denosumab) on prevention of steroid-induced osteoporosis in patients with autoimmune hepatitis (AIH)Biopsy-proven AIH patients who are planned or undergoing oral steroid therapy for more than 3 monthsJPRN-UMIN000013659Juntendo University School of Medicine80
已完成
不适用
Efficacy of anti-RANKL human antibody (Denosumab) on prevention of osteoporosis with primary biliary cirrhosisOsteoporosis in biopsy-proven PBC who was not pretreated with denosumab and/or bisphosphonate in recent 6 monthsJPRN-UMIN000012489Juntendo University School of Medicine20